Feuerstein's Biotech-Stock Mailbag

I'm hoping that Exelixis livens up going into the American Society of Clinical Oncology annual meeting at the end of May.

---

Let me close this week's Mailbag with a really nice note from Matthew S. remarking on my RealMoney coverage of last week's FDA advisory panel meeting for Amgen'sAMGN anemia drugs in cancer.

"Adam, thanks for the fantastic coverage on Amgen today. My trades in Amgen alone today more than paid for my subscription to RealMoney. Thanks for giving me the rest of the year for free."

Awesome. That's about the best feedback I can get from a reader, so thanks so much.

For those of you who don't subscribe to RealMoney, you should check it out. While most of my columns are published to TheStreet.com and are available for free, I do post a lot of (hopefully) valuable biotech insights and analyses on the RealMoney "Columnist Conversation" feature, available only to paid subscribers.

1 What would best describe your stance heading into the coming week of trading? Bullish Bearish Neutral 2 Which of these sectors do you think is set to move up in the coming week? --Choose One--Aerospace and DefenseAirlinesAutomobilesBeverages and Food ProductsBiotechnologyCommercial BanksComputers and PeripheralsConsumer NondurablesEnergy Equipment & ServicesHMOs and HospitalsHomebuildingInsuranceIntegrated OilInternet, Software ServicesInvestment Bankers and BrokersMediaMultiline RetailPharmaceuticalsPrecious MetalsSemis, Semi EquipmentTelecom EquipmentTobacco and AlcoholWireless CommunicationsUtilities 3 Which of these sectors do you think is set to move down in the coming week? --Choose One--Aerospace and DefenseAirlinesAutomobilesBeverages and Food ProductsBiotechnologyCommercial BanksComputers and PeripheralsConsumer NondurablesEnergy Equipment & ServicesHMOs and HospitalsHomebuildingInsuranceIntegrated OilInternet, Software ServicesInvestment Bankers and BrokersMediaMultiline RetailPharmaceuticalsPrecious MetalsSemis, Semi EquipmentTelecom EquipmentTobacco and AlcoholWireless CommunicationsUtilities View the results without voting